Bayer Cropscience profitability ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
23.7%19.9%26.6%
12.6%11.5%16.0%
25.3%20.1%29.8%
Margins
15.4%12.6%18.7%
13.7%11.1%17.2%
86.8%−74.4%—
15.1%12.9%18.4%
12.1%10.4%14.5%
18.3%—17.8%
Additional
19.4%19.7%21.3%
81.7%——
4.3%19.9%26.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,289.80

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Returns
Return on Common Equity—26.6319.9323.70
Return on Assets—15.9711.5412.59
Return on Capital Employed—29.8320.0825.34
Margins
EBITDA Margin—18.6912.6015.40
Operating Margin—17.2411.0513.74
Incremental Operating Margin——-74.3786.81
Pretax Margin—18.4512.9215.06
Net Income Margin—14.5110.3812.14
FCF Margin—17.75—18.30
Additional
Effective Tax Rate—21.3419.7119.38
Dvd Payout Ratio———81.66
Sustainable Growth Rate—26.6319.934.35
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.